Projects
View
Name | PD-MIND |
---|---|
Long Name | Parkinson disease with mild cognition impairment treated with nicotinic agonist drug |
Description | Parkinson disease with mild cognition impairment treated with nicotinic agonist drug. Currently, there is an unmet clinical need to treat Parkinson's disease with Mild Cognitive Impairment (PD-MCI). In fact, nicotinic agonists are specifically relevant for this condition. Hence, the major aim of the PD-MIND project is to identify the potential of the nicotinic α7 agonist AZD0328 in a randomized, placebo-controlled, parallel group, international multicentre study on cognitive function in people diagnosed with PD-MCI. |
Objectives | 1. Determine the effectiveness of AZD0328 on cognitive decline in people with Parkinson as a primary outcome measure in PD-MCI. 2. Identify the most relevant cognitive areas improved by AZD0328, and the underlying mechanisms involved. |
Website | https://www.imi.europa.eu/projects-results/project-factsheets/pd-mind |
Start date | 01-05-2019 |
End date | 30-04-2022 |
Logo |
Name | Projects | Type of institution | Country | |
---|---|---|---|---|
King's College London | PHAGO RADAR-CNS RADAR-AD EMIF PD-MIND EPND | Academia | United Kingdom | |
Astrazeneca AB | MOPEAD PHAGO Mobilise-D IDEA-FAST PD-MIND Pharma-Cog | EFPIA | Sweden | |
Helse Stavanger Hf | IDEA-FAST PD-MIND | Academia | Norway | |
Masarykova Univerzita | PD-MIND | Academia | Czech Republic | |
Technische Universitaet Dresden | PD-MIND | Academia | Germany | |
Universita Degli Studi Gabriele D'Annunzio Di Chieti-Pescara | PD-MIND | Academia | Italy | |
Norges Parkinsonforbund | PD-MIND | Patient/carers organisation | Norway | |
Parkinson's Disease Society Of The United Kingdom LBG | NEURONET PD-MitoQUANT IDEA-FAST PD-MIND | Patient/carers organisation | United Kingdom | |
University Of Exeter | PRISM EMIF PD-MIND Pharma-Cog | Academia | United Kingdom | |
Lygature | RADAR-CNS RADAR-AD PD-MIND EPND | SME | Netherlands |
WP number | Description | Project | |
---|---|---|---|
WP1 | Management | PD-MIND | |
WP2 | Clinical Trial | PD-MIND | |
WP3 | Data Management and analysis | PD-MIND | |
WP4 | Biomarker component | PD-MIND | |
WP5 | Dissemination and Exploitation | PD-MIND | |
WP6 | Ethics | PD-MIND |
Deliverable number | Title | Project | Submission date | Link | Keywords | |
---|---|---|---|---|---|---|
D5.5 | Exploitation plan | PD-MIND | 14-04-2020 | https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5d46e6fe2&appId=PPGMS | ||
D5.2 | Communication and dissemination plan, including (scientific) publications | PD-MIND | 29-09-2019 | https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5d46e54f7&appId=PPGMS | ||
D5.1 | Project website (EN) | PD-MIND | 12-11-2019 | https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5c966542b&appId=PPGMS | ||
D5.3 | Translated patient webpages (DE, IT, CZ, NO) | PD-MIND | 17-03-2020 | https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5cd3217a2&appId=PPGMS | ||
D5.6 | Exploitation plan (updated version) | PD-MIND | 03-04-2021 | https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5da78cea7&appId=PPGMS | ||
D5.8 | Communication and dissemination plan, including (scientific) publication – updated version | PD-MIND | 10-05-2021 | https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5dceafc33&appId=PPGMS |
Title | First author last name | Year | Project | Link | Keywords | |||||
---|---|---|---|---|---|---|---|---|---|---|
No entries in table |
Title | Description | Type | Project | |||||||
---|---|---|---|---|---|---|---|---|---|---|
No entries in table |
Back to list